DNA demethylating therapy in MDS:: The experience with 5-AZA-2′-deoxycytidine (decitabine).

被引：0
|
作者：
Wijermans, P
Luebbert, M
Verhoef, G
Bosly, A
Ravoet, C
Andre, M
Ferrant, A
Haak, H
机构：
[1] Leyenburg Hosp, Dept Haematol, The Hague, Netherlands
[2] Univ Freiburg, Freiburg, Germany
[3] Univ Grootgasthuisberg, Louvain, Belgium
[4] Mt Godinne UCL, Yvoir, Belgium
[5] Hosp Jolimont, Haine St Paul, Belgium
[6] Hosp Notre Dame, Charleroi, Belgium
[7] Clin Univ St Luc, B-1200 Brussels, Belgium
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1368
引用
收藏
页码：306A / 306A
页数：1
相关论文
共 50 条
  • [31] The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma
    Natsume, Atsushi
    Wakabayashi, Toshihiko
    Tsujimura, Kunio
    Shimato, Shinji
    Ito, Motokazu
    Kuzushima, Kiyotaka
    Kondo, Yutaka
    Sekido, Yoshitaka
    Kawatsura, Hitomi
    Narita, Yuji
    Yoshida, Jun
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (11) : 2542 - 2553
  • [32] A Perspective on the Comparative Antileukemic Activity of 5-Aza-2 '-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
    Momparler, Richard L.
    PHARMACEUTICALS, 2012, 5 (08): : 875 - 881
  • [33] Demethylating agent 5-aza-2′-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to cisplatin
    Shang, Donghao
    Liu, Yuting
    Matsui, Yoshiyuki
    Ito, Noriyuk
    Nishiyama, Hiroyuki
    Kamoto, Toshiyuki
    Ogawa, Osamu
    UROLOGY, 2008, 71 (06) : 1220 - 1225
  • [34] KINETICS OF PHOSPHORYLATION OF 5-AZA-2'-DEOXYCYTIDINE BY DEOXYCYTIDINE KINASE
    MOMPARLER, RL
    DERSE, D
    BIOCHEMICAL PHARMACOLOGY, 1979, 28 (08) : 1443 - 1444
  • [35] Profiling proteins in cells after treatment with the hypomethylating agent 5-aza-2 deoxycytidine (Decitabine).
    Stuart, D
    Twelves, C
    Brown, R
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3685S - 3685S
  • [36] Mutagenicity of 5-aza-2'-deoxycytidine is mediated by the mammalian DNA methyltransferase
    JacksonGrusby, L
    Laird, PW
    Magge, SN
    Moeller, BJ
    Jaenisch, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4681 - 4685
  • [37] Potential of 5-aza-2′-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer
    Momparler, RL
    Ayoub, J
    LUNG CANCER, 2001, 34 : S111 - S115
  • [38] 5-AZA-2'-DEOXYCYTIDINE - CELL-DIFFERENTIATION AND DNA METHYLATION
    TAYLOR, SM
    LEUKEMIA, 1993, 7 : 3 - 8
  • [39] Pharmacokinetic and pharmacodynamic analysis of 5-aza-2′-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
    Karahoca, Metin
    Momparler, Richard L.
    CLINICAL EPIGENETICS, 2013, 5
  • [40] Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide
    Sandra Coral
    Giulia Parisi
    Hugues J. M. G. Nicolay
    Francesca Colizzi
    Riccardo Danielli
    Elisabetta Fratta
    Alessia Covre
    Pietro Taverna
    Luca Sigalotti
    Michele Maio
    Cancer Immunology, Immunotherapy, 2013, 62 : 605 - 614
12345